Using Traditional Chinese Medicine to Treat Hepatocellular Carcinoma by Targeting Tumor Immunity

Overview

Journal Evid Based Complement Alternat Med

Specialty Rehabilitation Medicine

Date 2020 Jun 30

PMID 32595757

Citations 12

Authors

Wentao Jia

Lina Wang

Affiliations

Soon will be listed here.

Abstract

As the leading cause of cancer-related death, hepatocellular carcinoma (HCC) threatens human health and limited treatments are available to cure the disease efficiently and effectively. The particularly immunotolerant environment of the liver lowers the efficacy of current therapies in patients with advanced HCC. Traditional Chinese medicine (TCM) is gathering increasing interest due to the immunoregulatory properties of certain compounds. In advanced HCC, TCM can restore immunosurveillance to promote antitumor effects in several ways, including the upregulation of immunostimulatory factors and the downregulation of immunosuppressive factors. The characteristic multitarget regulation of TCM compounds may provide new insights regarding effective HCC immunotherapies. Here, we review the immunoregulatory potency of TCMs for treating HCC and explain how individual TCM drugs and complex formulas remodel the immune environment in various cell- and cytokine-dependent manners.

Citing Articles

Huqi formula suppresses hepatocellular carcinoma growth by modulating the PI3K/AKT/mTOR pathway and promoting T cell infiltration.

Yin D, Li X, Yang X, Shang X, Li Z, Geng J Chin Med. 2025; 20(1):25.

PMID: 39972480 PMC: 11837637. DOI: 10.1186/s13020-025-01061-w.

Perceptions in 3.6 Million Web-Based Posts of Online Communities on the Use of Cancer Immunotherapy: Data Mining Using BERTopic.

Wu X, Lam C, Hui K, Loong H, Zhou K, Ngan C J Med Internet Res. 2025; 27:e60948.

PMID: 39928933 PMC: 11851037. DOI: 10.2196/60948.

Network pharmacology‑based analysis and experimental verification of the inhibitory role of luteoloside on gastric cancer cells via the p53/p21 pathway.

Lin X, Yang P, Li X, Xu Z, Wu H, Hu S Oncol Lett. 2024; 29(2):76.

PMID: 39650229 PMC: 11622105. DOI: 10.3892/ol.2024.14822.

New perspectives on chemokines in hepatocellular carcinoma therapy: a critical pathway for natural products regulation of the tumor microenvironment.

Ruishi X, Linyi X, Yunfan B, Wenbo Y, Xiaoying Z, Xiaoxue F Front Immunol. 2024; 15:1456405.

PMID: 39206194 PMC: 11349538. DOI: 10.3389/fimmu.2024.1456405.

Progress in the Regulation of Immune Cells in the Tumor Microenvironment by Bioactive Compounds of Traditional Chinese Medicine.

Chen Y, Fan W, Zhao Y, Liu M, Hu L, Zhang W Molecules. 2024; 29(10).

PMID: 38792234 PMC: 11124165. DOI: 10.3390/molecules29102374.

References

Lu X, Wo G, Li B, Xu C, Wu J, Jiang C . The anti-inflammatory NHE-06 restores antitumor immunity by targeting NF-κB/IL-6/STAT3 signaling in hepatocellular carcinoma. Biomed Pharmacother. 2018; 102:420-427. DOI: 10.1016/j.biopha.2018.03.099. View

Cao Z, Chen X, Liao L, Peng J, Hu H, Liu Z . Fuzheng Yiliu Granule inhibits the growth of hepatocellular cancer by regulating immune function and inducing apoptosis in vivo and in vitro. Chin J Integr Med. 2011; 17(9):691-7. DOI: 10.1007/s11655-011-0847-3. View

Dai B, Qi J, Liu R, Zhang Y . Eupolyphaga sinensis Walker demonstrates angiogenic activity and inhibits A549 cell growth by targeting the KDR signaling pathway. Mol Med Rep. 2014; 10(3):1590-6. DOI: 10.3892/mmr.2014.2387. View

Han L, Li J, Huang F, Yu S, Fang N . Triterpenoid saponins from Anemone flaccida induce apoptosis activity in HeLa cells. J Asian Nat Prod Res. 2009; 11(2):122-7. DOI: 10.1080/10286020802573818. View

Fu Y, Liu S, Zeng S, Shen H . From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma. J Exp Clin Cancer Res. 2019; 38(1):396. PMC: 6734524. DOI: 10.1186/s13046-019-1396-4. View

Wang M, Wang H, Tang Y, Kang D, Gao Y, Ke M . Effective inhibition of a Strongylocentrotus nudus eggs polysaccharide against hepatocellular carcinoma is mediated via immunoregulation in vivo. Immunol Lett. 2011; 141(1):74-82. DOI: 10.1016/j.imlet.2011.08.001. View

Chen J, Li E, Dai C, Yu B, Wu X, Huang C . The inducible effect of LBP on maturation of dendritic cells and the related immune signaling pathways in hepatocellular carcinoma (HCC). Curr Drug Deliv. 2012; 9(4):414-20. DOI: 10.2174/156720112801323107. View

Liu H, Chou G, Guo Y, Ji L, Wang J, Wang Z . Norclerodane diterpenoids from rhizomes of Dioscorea bulbifera. Phytochemistry. 2010; 71(10):1174-80. DOI: 10.1016/j.phytochem.2010.04.002. View

Han L, Yao S, Cao S, Mo G, Li J, Cao Y . Triterpenoid Saponins from Suppress Tumor Cell Proliferation by Regulating MAPK, PD1/PDL1, and STAT3 Signaling Pathways and Altering Cancer Metabolism. Onco Targets Ther. 2019; 12:10917-10930. PMC: 6913295. DOI: 10.2147/OTT.S212666. View

10.

Wang S, Liu Y, Feng Y, Zhang J, Swinnen J, Li Y . A Review on Curability of Cancers: More Efforts for Novel Therapeutic Options Are Needed. Cancers (Basel). 2019; 11(11). PMC: 6896199. DOI: 10.3390/cancers11111782. View

11.

Hilmi M, Vienot A, Rousseau B, Neuzillet C . Immune Therapy for Liver Cancers. Cancers (Basel). 2020; 12(1). PMC: 7016834. DOI: 10.3390/cancers12010077. View

12.

Liao Y, Lin C, Lai H, Chiang J, Lin J, Li T . Adjunctive traditional Chinese medicine therapy improves survival of liver cancer patients. Liver Int. 2015; 35(12):2595-602. DOI: 10.1111/liv.12847. View

13.

Li S, Wang X, Ren L, Li J, Zhu X, Xing T . Protective effects of γ-irradiated Astragalus polysaccharides on intestinal development and mucosal immune function of immunosuppressed broilers. Poult Sci. 2019; 98(12):6400-6410. PMC: 8913762. DOI: 10.3382/ps/pez478. View

14.

Xu H, Wei W, Y M, Dong C . Efficacy and safety of Chinese patent medicine (Jinlong capsule) in the treatment of advanced hepatocellular carcinoma: a meta-analysis. Biosci Rep. 2019; 40(1). PMC: 6970085. DOI: 10.1042/BSR20194019. View

15.

Huang Z, Wang Y, Chen J, Wang R, Chen Q . Effect of Xiaoaiping injection on advanced hepatocellular carcinoma in patients. J Tradit Chin Med. 2013; 33(1):34-8. DOI: 10.1016/s0254-6272(13)60097-7. View

16.

Alexander D . A method for interdicting the development of severe jaundice in newborns by inhibiting the production of bilirubin. Pediatrics. 2004; 113(1 Pt 1):135. DOI: 10.1542/peds.113.1.135. View

17.

Zhang N, Zhao Y, Shi Y, Chen R, Fu X, Zhao Y . Polypeptides extracted from Eupolyphaga sinensis walker via enzymic digestion alleviate UV radiation-induced skin photoaging. Biomed Pharmacother. 2019; 112:108636. DOI: 10.1016/j.biopha.2019.108636. View

18.

Hong Y, Wu H, Ma T, Liu W, He X . Effects of Glycyrrhiza glabra polysaccharides on immune and antioxidant activities in high-fat mice. Int J Biol Macromol. 2009; 45(1):61-4. DOI: 10.1016/j.ijbiomac.2009.04.001. View

19.

El-Khoueiry A, Sangro B, Yau T, Crocenzi T, Kudo M, Hsu C . Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial. Lancet. 2017; 389(10088):2492-2502. PMC: 7539326. DOI: 10.1016/S0140-6736(17)31046-2. View

20.

Greten T, Lai C, Li G, Staveley-OCarroll K . Targeted and Immune-Based Therapies for Hepatocellular Carcinoma. Gastroenterology. 2018; 156(2):510-524. PMC: 6340758. DOI: 10.1053/j.gastro.2018.09.051. View